扬子江药业集团江苏紫龙药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
19
NMPA:19
Drug Approvals
Acetylcysteine Solution for Inhalation
- Product Name
- 吸入用乙酰半胱氨酸溶液
- Approval Number
- 国药准字H20243641
- Approval Date
- Apr 30, 2024
NMPA
Tedizolid Phosphate Tablets
- Product Name
- 磷酸特地唑胺片
- Approval Number
- 国药准字H20243454
- Approval Date
- Apr 7, 2024
NMPA
Roxatidine Acetate Hydrochloride For Injection
- Product Name
- 注射用盐酸罗沙替丁醋酸酯
- Approval Number
- 国药准字H20233994
- Approval Date
- Aug 1, 2023
NMPA
Levornidazole Disodium Phosphate for Injection
- Product Name
- 新锐
- Approval Number
- 国药准字H20227110
- Approval Date
- Aug 30, 2022
NMPA
Levornidazole Disodium Phosphate for Injection
- Product Name
- 新锐
- Approval Number
- 国药准字H20227072
- Approval Date
- May 31, 2022
NMPA
Dapoxetine Hydrochloride Tablets
- Product Name
- 盐酸达泊西汀片
- Approval Number
- 国药准字H20213932
- Approval Date
- Dec 14, 2021
NMPA
Rupatadine Fumarate Tablets
- Product Name
- 富马酸卢帕他定片
- Approval Number
- 国药准字H20173112
- Approval Date
- Dec 6, 2021
NMPA
Nalbuphine Hydrochloride Injection
- Product Name
- 盐酸纳布啡注射液
- Approval Number
- 国药准字H20213884
- Approval Date
- Nov 24, 2021
NMPA
Moxifloxacin Hydrochloride Tablets
- Product Name
- 盐酸莫西沙星片
- Approval Number
- 国药准字H20213553
- Approval Date
- Jun 29, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found